FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to benzo-N-hydroxyamide compounds of formula (I), pharmaceutically acceptable salts or isomers thereof, having tumor cell proliferation inhibitory activity, as well as a based pharmaceutical composition. Compounds can be used for treating tan diseases, particularly colorectal cancer or haematological malignancies. In general formula (I), n is 0, 1 or 2; A is absent or is 5–6 membered mono- or 9–10-member di-carbocyclic residue, optionally partially or completely unsaturated, containing carbon atoms and optionally one or two heteroatoms selected from N and S; R1 and R2 are independently selected from a group comprising -H, -OH, -OMe, -CN, -NH2, -NO2, -Cl, -COOH and -CH2N(CH2CH3)2; X can be C or N; R3 and R4 are independently selected from a group comprising -H, -OMe, -OPh, -NO2, -NMe2 and -NH2, or R3 and R4 together can form a heteropentacyclic group (-OCH2O-).
(I)
EFFECT: disclosed are benzo-N-hydroxyamide compounds having anti-tumor activity.
10 cl, 5 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
SELECTIVE HDAC6 INHIBITORS | 2018 |
|
RU2764718C2 |
IMPROVED APELIN RECEPTOR AGONISTS (APJ) AND THEIR USE | 2016 |
|
RU2766148C1 |
SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS | 2012 |
|
RU2604522C2 |
NEUROTENSIN RECEPTOR LIGANDS | 2013 |
|
RU2671970C2 |
QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS | 2015 |
|
RU2721723C2 |
LOW-MOLECULAR CONJUGATES FOR INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE COMPOUNDS | 2011 |
|
RU2629957C2 |
CYTOTOXIC PEPTIDES AND ANTIBODY-DRUG CONJUGATES THEREOF | 2012 |
|
RU2586885C2 |
METHOD FOR TREATING RETROVIRUS INFECTION IN MAMMALIAN | 1995 |
|
RU2166317C2 |
LOW-MOLECULAR CONJUGATES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS | 2011 |
|
RU2582235C2 |
SPLICEOSTATIN ANALOGS | 2013 |
|
RU2618523C2 |
Authors
Dates
2020-11-30—Published
2017-07-14—Filed